moxifloxacin has been researched along with Infection, Wound in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chhibber, T; Gondil, VS; Sinha, VR | 1 |
| Borges, FA; de Barros, NR; de Souza Salvador, SL; Del Arco, MC; Frade, MAC; Garms, BC; Herculano, RD; Leite, MN; Marcelino, MY; Oliveira, KSM; Pegorin, GS | 1 |
| Hussain, T; Liaqat, F; Muhammad, J; Nazir, J; Rabbani, M; Shaheen, AY; Sheikh, AA | 1 |
| Fisahn, C; Fugmann, B; Hirsch, T; Jacobsen, F; Klaassen, T; Roemer, A; Sorkin, M; Steinstraesser, L; Stricker, I; Thiele, I | 1 |
| Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S | 1 |
| Bogner, JR; Draenert, R; Hellers, J; Kunzelmann, M; Roggenkamp, A | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
7 other study(ies) available for moxifloxacin and Infection, Wound
| Article | Year |
|---|---|
Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Biofilms; Boswellia; Burns; Chitosan; Drug Compounding; Gels; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2020 |
Novel polymeric dressing to the treatment of infected chronic wound.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bandages; Cell Line; Drug Delivery Systems; Escherichia coli; Fibroblasts; Humans; Keratinocytes; Latex; Mice; Microbial Sensitivity Tests; Moxifloxacin; Polymers; Pseudomonas aeruginosa; Rubber; Wound Healing; Wound Infection | 2019 |
Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cinnamomum zeylanicum; Clindamycin; Curcuma; Fluoroquinolones; Garlic; Humans; Linezolid; Mentha; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Nigella sativa; Oxazolidinones; Pakistan; Plant Extracts; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Syzygium; Vancomycin Resistance; Wound Infection | 2015 |
Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Topics: Administration, Topical; Animals; Aza Compounds; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas aeruginosa; Quinolines; Rats; Swine; Wound Infection | 2011 |
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections.
Topics: Abdominal Injuries; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Aerobic; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Respiratory Tract Infections; Wound Infection | 2004 |
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bites and Stings; Cats; Cefuroxime; Ciprofloxacin; Female; Fluoroquinolones; Humans; Middle Aged; Moxifloxacin; Pasteurella Infections; Quinolines; Streptococcal Infections; Treatment Failure; Wound Infection | 2005 |
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Wound Infection | 1997 |